ATE408401T1 - Granulat oder pulver zur herstellung von überzugs-und bindemitteln für arzneiformen - Google Patents
Granulat oder pulver zur herstellung von überzugs-und bindemitteln für arzneiformenInfo
- Publication number
- ATE408401T1 ATE408401T1 AT03790791T AT03790791T ATE408401T1 AT E408401 T1 ATE408401 T1 AT E408401T1 AT 03790791 T AT03790791 T AT 03790791T AT 03790791 T AT03790791 T AT 03790791T AT E408401 T1 ATE408401 T1 AT E408401T1
- Authority
- AT
- Austria
- Prior art keywords
- sub
- granules
- powder
- powders
- mixed
- Prior art date
Links
- 239000008187 granular material Substances 0.000 title abstract 3
- 239000011230 binding agent Substances 0.000 title abstract 2
- 239000011248 coating agent Substances 0.000 title abstract 2
- 238000000576 coating method Methods 0.000 title 1
- 239000000843 powder Substances 0.000 abstract 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 abstract 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 abstract 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229920001577 copolymer Polymers 0.000 abstract 1
- 239000002537 cosmetic Substances 0.000 abstract 1
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 239000003995 emulsifying agent Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000155 melt Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000178 monomer Substances 0.000 abstract 1
- 125000001302 tertiary amino group Chemical group 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- General Preparation And Processing Of Foods (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10239999A DE10239999A1 (de) | 2002-08-27 | 2002-08-27 | Granulat oder Pulver zur Herstellung von Überzugs- und Bindemitteln für Arzneiformen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE408401T1 true ATE408401T1 (de) | 2008-10-15 |
Family
ID=31197526
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03790791T ATE408401T1 (de) | 2002-08-27 | 2003-07-08 | Granulat oder pulver zur herstellung von überzugs-und bindemitteln für arzneiformen |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7175857B2 (enExample) |
| EP (1) | EP1432409B1 (enExample) |
| JP (1) | JP4571861B2 (enExample) |
| KR (1) | KR100942667B1 (enExample) |
| AT (1) | ATE408401T1 (enExample) |
| AU (1) | AU2003266232A1 (enExample) |
| BR (1) | BRPI0306143B8 (enExample) |
| CA (1) | CA2464502C (enExample) |
| DE (2) | DE10239999A1 (enExample) |
| ES (1) | ES2314275T3 (enExample) |
| IL (2) | IL161145A0 (enExample) |
| IN (1) | IN2004CH00875A (enExample) |
| MX (1) | MX250472B (enExample) |
| PL (1) | PL206233B1 (enExample) |
| SI (1) | SI1432409T1 (enExample) |
| WO (1) | WO2004019918A1 (enExample) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10208344A1 (de) | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Schmelzextrusion von Wirkstoffsalzen |
| DE10260921A1 (de) * | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zum Überziehen von Substraten für pharmazeutische Anwendungen mit einem Gemisch aus zwei filmbildenden Überzugsmitteln |
| DE10260920A1 (de) * | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von Arnzeiformen oder Nahrungsergänzungsmitteln mit pigmentierten Polymerüberzügen |
| DE10260919A1 (de) * | 2002-12-20 | 2004-07-01 | Röhm GmbH & Co. KG | Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug |
| DE10304403A1 (de) * | 2003-01-28 | 2004-08-05 | Röhm GmbH & Co. KG | Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung |
| DE102004029573A1 (de) * | 2004-06-18 | 2005-12-29 | Gambro Lundia Ab | MIF-Adsorbent |
| WO2006046560A1 (ja) * | 2004-10-29 | 2006-05-04 | Taiho Pharmaceutical Co., Ltd. | プロピベリン含有経口粉粒状製剤及びその製造法 |
| EP1681049A1 (fr) * | 2005-01-12 | 2006-07-19 | Physica Pharma | Composition pharmaceutique et forme galénique correspondante à délitement rapide en bouche, et procédé de fabrication de cette composition |
| EP1879583A2 (en) * | 2005-05-03 | 2008-01-23 | Mutual Pharmaceutical Company, Inc. | Quinine formulations |
| DE102005042039A1 (de) * | 2005-09-02 | 2007-03-08 | Basf Ag | Wässrige Polyvinylacetatdispersionen mit hoher Scherstabilität |
| PT2046300E (pt) * | 2006-08-04 | 2010-07-01 | Ethypharm Sa | Comprimido multicamadas de desintegraão oral |
| CN101778870B (zh) | 2007-08-02 | 2012-11-07 | 巴斯夫欧洲公司 | 基于甲基丙烯酸n，n-二乙基氨基乙酯的聚合物水分散体，其制备及用途 |
| WO2010030735A2 (en) * | 2008-09-11 | 2010-03-18 | Aethos Pharmaceuticals, Inc. | Stabilized coating for pharmaceutical formulations |
| CN102665688A (zh) | 2009-10-28 | 2012-09-12 | 巴斯夫欧洲公司 | 用于药物剂型的稳定保护性包衣 |
| US20110150986A1 (en) * | 2009-12-18 | 2011-06-23 | Kristin Arnold | Quinine formulations, method of making, and metho of use thereof |
| AU2011226324B2 (en) * | 2010-03-10 | 2015-09-24 | Nogra Pharma Limited | Compositions for colon lavage and methods of making and using same |
| JP2013526495A (ja) | 2010-05-10 | 2013-06-24 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツング | １種以上の抗レトロウイルス活性成分を有する製薬学的剤形 |
| WO2012031934A1 (de) | 2010-09-07 | 2012-03-15 | Basf Se | Verwendung von copolymeren auf basis von aminogruppenhaltigen polymeren als matrixbindemittel für die herstellung von wirkstoffhaltigen granulaten und darreichungsformen |
| CN103221038B (zh) | 2010-09-27 | 2019-05-07 | 巴斯夫欧洲公司 | 酸性活性成分的保护涂层 |
| US9795576B2 (en) * | 2010-09-27 | 2017-10-24 | Basf Se | Protective coatings for acidic active ingredients |
| CN103347931B (zh) | 2011-02-28 | 2016-02-17 | 巴斯夫欧洲公司 | 制备用于药物剂型的稳定保护性衣层的粉末包衣剂 |
| JP5937113B2 (ja) | 2011-02-28 | 2016-06-22 | ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ | 医薬剤形用の安定した保護被覆のための粉末被覆剤の製造 |
| US8865250B2 (en) | 2011-02-28 | 2014-10-21 | Basf Se | Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms |
| US8962064B2 (en) | 2011-02-28 | 2015-02-24 | Basf Se | Production of pulverulent coating compositions for stable protective coatings for pharmaceutical dosage forms |
| US9044734B2 (en) | 2011-09-23 | 2015-06-02 | Basf Se | Diesel oxidation catalyst with layered structure containing ceria composition as palladium support material for enhanced HC and CO gas conversion |
| US20130236505A1 (en) | 2012-03-09 | 2013-09-12 | Basf Se | Production Of Pharmaceutical Protective Coatings With Good Resistance In A Neutral Environment |
| EP2636403A1 (de) * | 2012-03-09 | 2013-09-11 | Basf Se | Herstellung von pharmazeutischen protektiven Überzügen mit guter Resistenz im neutralen Milieu |
| US10668156B2 (en) | 2012-06-22 | 2020-06-02 | Basf Se | Active-ingredient-containing solid dispersions based on diethylaminoethyl methacrylate copolymers |
| CN104379174B (zh) | 2012-06-22 | 2018-01-26 | 巴斯夫欧洲公司 | 基于甲基丙烯酸二乙基氨基乙酯共聚物的含活性成分固体分散体 |
| HK1213932A1 (zh) * | 2012-11-22 | 2016-07-15 | 赢创罗姆有限公司 | 由粉末组合物制备颗粒状产品的方法 |
| FR3027802B1 (fr) * | 2014-10-31 | 2018-03-02 | Ethypharm | Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant |
| GR1008992B (el) * | 2015-12-17 | 2017-03-23 | Verisfield (Uk) Ltd, Υποκαταστημα Ελλαδας, Εμπορια Φαρμακων | Φαρμακευτικη συνθεση σε μορφη κοκκιων για χορηγηση απο το στομα που περιεχει μετρονιδαζολη ή παραγωγα αυτης και εναν παραγοντα καλυψης της γευσης |
| EP3569225A1 (en) * | 2018-05-18 | 2019-11-20 | Pharmaceutical Oriented Services Ltd | Solid dispersion containing ritonavir |
| WO2020138407A1 (ja) * | 2018-12-27 | 2020-07-02 | 興和株式会社 | 医薬品 |
| CN116887866A (zh) | 2020-12-03 | 2023-10-13 | 巴特尔纪念研究院 | 聚合物纳米颗粒和dna纳米结构组合物及用于非病毒递送的方法 |
| JP2024516108A (ja) | 2021-04-07 | 2024-04-12 | バテル・メモリアル・インスティテュート | 非ウイルス性担体を同定および使用するための迅速な設計、構築、試験、および学習技術 |
| WO2025072751A1 (en) | 2023-09-29 | 2025-04-03 | Battelle Memorial Institute | Polymer nanoparticle compositions for in vivo expression of polypeptides |
| US12441996B2 (en) | 2023-12-08 | 2025-10-14 | Battelle Memorial Institute | Use of DNA origami nanostructures for molecular information based data storage systems |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0164669B1 (de) * | 1984-06-13 | 1991-01-23 | Röhm Gmbh | Verfahren zum Überziehen von Arzneiformen |
| DE3920082A1 (de) * | 1989-06-20 | 1991-03-07 | Roehm Gmbh | Filmbildendes waessriges ueberzugsmittel fuer feste arzneimittel, verfahren zu seiner herstellung und verwendung |
| DE29502547U1 (de) * | 1995-02-16 | 1995-03-30 | Röhm GmbH, 64293 Darmstadt | Thermoplastisches Überzugs- und Bindemittel für Arzneiformen |
| DE19918435A1 (de) * | 1998-07-23 | 2000-01-27 | Roehm Gmbh | Überzugs- und Bindemittel für orale oder dermale Arzneiformen |
| DE19958007A1 (de) | 1999-12-02 | 2001-06-07 | Roehm Gmbh | Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen |
| DK1311820T3 (en) * | 2000-07-14 | 2015-04-07 | Janssen Diagnostics Llc | Increased separation efficiency via a controlled aggregation of magnetic nanoparticles |
| HU229344B1 (en) * | 2001-02-27 | 2013-11-28 | Evonik Roehm Gmbh | Coating and binding agent for pharmaceutical formulations with improved storage stability |
| DE10208344A1 (de) | 2002-02-27 | 2003-09-04 | Roehm Gmbh | Schmelzextrusion von Wirkstoffsalzen |
-
2002
- 2002-08-27 DE DE10239999A patent/DE10239999A1/de not_active Withdrawn
-
2003
- 2003-07-08 PL PL368186A patent/PL206233B1/pl unknown
- 2003-07-08 US US10/489,856 patent/US7175857B2/en not_active Expired - Lifetime
- 2003-07-08 CA CA2464502A patent/CA2464502C/en not_active Expired - Lifetime
- 2003-07-08 ES ES03790791T patent/ES2314275T3/es not_active Expired - Lifetime
- 2003-07-08 SI SI200331454T patent/SI1432409T1/sl unknown
- 2003-07-08 WO PCT/EP2003/007319 patent/WO2004019918A1/de not_active Ceased
- 2003-07-08 EP EP03790791A patent/EP1432409B1/de not_active Expired - Lifetime
- 2003-07-08 DE DE50310506T patent/DE50310506D1/de not_active Expired - Lifetime
- 2003-07-08 JP JP2004531794A patent/JP4571861B2/ja not_active Expired - Lifetime
- 2003-07-08 IL IL16114503A patent/IL161145A0/xx unknown
- 2003-07-08 MX MXPA04003970 patent/MX250472B/es active IP Right Grant
- 2003-07-08 BR BRPI0306143A patent/BRPI0306143B8/pt active IP Right Grant
- 2003-07-08 AU AU2003266232A patent/AU2003266232A1/en not_active Abandoned
- 2003-07-08 AT AT03790791T patent/ATE408401T1/de active
-
2004
- 2004-03-29 IL IL161145A patent/IL161145A/en active IP Right Grant
- 2004-04-26 IN IN875CH2004 patent/IN2004CH00875A/en unknown
- 2004-04-27 KR KR20047006270A patent/KR100942667B1/ko not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0306143B8 (pt) | 2021-05-25 |
| DE10239999A1 (de) | 2004-03-04 |
| IL161145A0 (en) | 2004-08-31 |
| PL368186A1 (en) | 2005-03-21 |
| ES2314275T3 (es) | 2009-03-16 |
| BR0306143A (pt) | 2004-10-19 |
| IL161145A (en) | 2010-11-30 |
| JP4571861B2 (ja) | 2010-10-27 |
| MX250472B (es) | 2007-10-17 |
| DE50310506D1 (de) | 2008-10-30 |
| AU2003266232A1 (en) | 2004-03-19 |
| MXPA04003970A (es) | 2004-06-22 |
| EP1432409A1 (de) | 2004-06-30 |
| WO2004019918A1 (de) | 2004-03-11 |
| PL206233B1 (pl) | 2010-07-30 |
| EP1432409B1 (de) | 2008-09-17 |
| BRPI0306143B1 (pt) | 2016-03-08 |
| KR20050034620A (ko) | 2005-04-14 |
| US7175857B2 (en) | 2007-02-13 |
| JP2005536555A (ja) | 2005-12-02 |
| IN2004CH00875A (enExample) | 2006-01-13 |
| CA2464502C (en) | 2010-11-23 |
| KR100942667B1 (ko) | 2010-02-17 |
| US20040249035A1 (en) | 2004-12-09 |
| CA2464502A1 (en) | 2004-03-11 |
| SI1432409T1 (sl) | 2009-02-28 |
| US20050197434A9 (en) | 2005-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50310506D1 (de) | Granulat oder pulver zur herstellung von überzugs- und bindemitteln für arzneiformen | |
| ATE305774T1 (de) | Überzugs- und bindemittel für arzneimittelformulierungen mit verbesserter lagerstabilität | |
| SG131109A1 (en) | Muteins of tear lipocalin | |
| ATE230426T1 (de) | Überzugs- und bindemittel für orale oder dermale arzneiformen | |
| AU2001279631A1 (en) | Self-emulsifying active substance formulation and use of this formulation | |
| DE59913682D1 (de) | Verfahren zur Herstellung von festen Dosierungsformen | |
| IL172700A (en) | Methods for making neutralizing and cross-activating antibodies against kir2dl and drugs that include them for use in assessing antibody toxicity | |
| WO2003028757A1 (en) | Novel method of inducing antigen-specific t cells | |
| IL164217A0 (en) | Pharmaceutical compositions containing water-soluble propofol and methods of administering same | |
| DE60211769D1 (de) | Verfahren zur Herstellung von Arzneistoffgranulatkörnern, die Arzneistoffgranulatkörner sowie diese enthaltende pharmazeutische Zubereitungen | |
| TWI284044B (en) | Hairdressing cosmetic composition | |
| CA2535013A1 (en) | Micro-particle fatty acid salt solid dosage formulations for therapeutic agents | |
| ATE293957T1 (de) | Verfahren zur herstellung von inhalationspulvern | |
| DE60214354D1 (de) | Verkettungsmittel und dieses enthaltende polyamidzusammensetzung | |
| DE60138131D1 (de) | Verfahren zur herstellung von methionin-haltigen granulaten | |
| AU2003271811A8 (en) | Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulphonates) and compositions containing same | |
| AU2002366200A1 (en) | Sfcyr iib or sfcyr iii for the treatment of auto-immune diseases | |
| TW200503687A (en) | Water-soluble isoflavon composition, manufacture method and usage thereof | |
| AU2002314972A1 (en) | Compressible guaifenesin compositions and method for producing them | |
| ZA961419B (en) | Human DNase I variants. | |
| ATE498394T1 (de) | Verfahren zur herstellung eines medikaments | |
| AU2001274138A1 (en) | Propanolaminotetralines, preparation thereof and compositions containing same | |
| RU2002116760A (ru) | Способ производства гранулированных кормов для рыб | |
| AU2003222445A1 (en) | Synergistic hepatoprotective composition and a method thereof | |
| DE602005026909D1 (de) | Ibopaminmaleat, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen, die dieses enthalten |